Mylan says EpiPen manufacturing partner to expand device recall

(Reuters) - Generic drugmaker Mylan NV said on Friday that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets.

Pharmacy chain works to help curb opioid epidemic

(Reuters Health) - The drugstore chain Walgreens is taking a three-pronged approach to combat the public health crisis stemming from prescription opioids, according to a team of pharmacists and other clinicians from the company.

Can grandma help spot autism earlier?

(Reuters Health) - Kids with autism who spend a lot of time with their grandmothers may get diagnosed with the disorder at a younger age, a small study suggests.

Freestanding ERs may give patients sticker shock

(Reuters Health) - Care at freestanding emergency departments may cost about 10 times more than similar treatment at urgent care centers, according to a Texas study that highlights the potential for patients to be surprised by their bills.

Overweight, obese young men at increased risk of liver disease

(Reuters Health) - Young men who are overweight or obese have up to double the risk of normal-weight peers for developing liver disease later in life, a large study in Sweden suggests.

U.S. Zika vaccine begins second phase of testing

CHICAGO (Reuters) - Researchers have begun the second phase of testing of a Zika vaccine developed by U.S. government scientists in a trial that could yield preliminary results as early as the end of 2017.

Biogen wins Tecfidera U.S. patent dispute with Forward Pharma

(Reuters) - A U.S. patent board on Friday ruled against Danish drugmaker Forward Pharma A/S, finding Biogen's patents on its blockbuster multiple sclerosis drug Tecfidera to be valid.

U.S. judge invalidates Acorda multiple sclerosis drug patents

(Reuters) - A federal judge in Delaware on Friday struck down key patents held by Acorda Therapeutics related to its multiple sclerosis drug Ampyra.

Youth with diabetes need vision loss screening

(Reuters Health) – Diabetes can lead to blindness, but children and teens with diabetes may not receive recommended eye exams in the years following their diagnosis, a U.S. study suggests.

NIAID begins vaccinations in a mid-stage trial for Zika

(Reuters) - The U.S. National Institute of Allergy and Infectious Diseases (NIAID) said on Friday that vaccinations have begun in a mid-stage trial testing an experimental DNA vaccine for Zika.

Philip Morris files U.S. FDA application for heated tobacco device

LONDON (Reuters) - Philip Morris International said on Friday it has applied for a pre-market approval of its iQOS heated tobacco product with the U.S. Food and Drug Administration.

Cholera spreads in famine-threatened Somalia

BURAO, Somalia (Reuters) - Deadly cholera is spreading through drought-ravaged Somalia as clean water sources dry up, a top aid official said, deepening a humanitarian crisis in a country that is on the verge of famine.

British robot helping autistic children with their social skills

LONDON (Reuters) - "This is nice, it tickles me," Kaspar the social robot tells four-year-old Finn as they play together at an autism school north of London.